Xu Shi

547 total citations
24 papers, 316 citations indexed

About

Xu Shi is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Molecular Biology. According to data from OpenAlex, Xu Shi has authored 24 papers receiving a total of 316 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 12 papers in Cancer Research and 10 papers in Molecular Biology. Recurrent topics in Xu Shi's work include Ferroptosis and cancer prognosis (14 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Epigenetics and DNA Methylation (5 papers). Xu Shi is often cited by papers focused on Ferroptosis and cancer prognosis (14 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Epigenetics and DNA Methylation (5 papers). Xu Shi collaborates with scholars based in China and United Kingdom. Xu Shi's co-authors include Dechao Feng, Qiao Xiong, Lu Yang, Qiang Wei, Facai Zhang, Dengxiong Li, Wuran Wei, Jia You, Ping Han and Jie Wang and has published in prestigious journals such as Frontiers in Immunology, Molecules and Immunology.

In The Last Decade

Xu Shi

24 papers receiving 316 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xu Shi China	12	165	153	146	58	44	24	316
Xiaoxia Gou China	8	94 0.6×	132 0.9×	157 1.1×	51 0.9×	42 1.0×	20	266
Svenja Adrian Germany	7	116 0.7×	39 0.3×	128 0.9×	103 1.8×	18 0.4×	14	270
Florinda Meléndez‐Rodríguez Spain	6	47 0.3×	135 0.9×	170 1.2×	38 0.7×	37 0.8×	6	280
Olena Preobrazhenska Canada	7	125 0.8×	60 0.4×	176 1.2×	86 1.5×	28 0.6×	7	339
Ram C. Shankaraiah Italy	10	56 0.3×	147 1.0×	188 1.3×	95 1.6×	20 0.5×	11	339
Andreas Domen Belgium	9	99 0.6×	33 0.2×	85 0.6×	106 1.8×	45 1.0×	15	271
Changjian Shao China	12	139 0.8×	88 0.6×	201 1.4×	144 2.5×	30 0.7×	23	369
Jingxia Chang China	10	119 0.7×	245 1.6×	316 2.2×	45 0.8×	35 0.8×	20	434
Shiyong Xin China	11	104 0.6×	232 1.5×	271 1.9×	51 0.9×	32 0.7×	30	382
Yanjing Guo China	10	81 0.5×	102 0.7×	209 1.4×	94 1.6×	36 0.8×	16	321

Countries citing papers authored by Xu Shi

Since Specialization

Citations

This map shows the geographic impact of Xu Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xu Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xu Shi more than expected).

Fields of papers citing papers by Xu Shi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xu Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xu Shi. The network helps show where Xu Shi may publish in the future.

Co-authorship network of co-authors of Xu Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Xu Shi. A scholar is included among the top collaborators of Xu Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xu Shi. Xu Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, Hao, Xu Shi, Naixi Yang, & Shiwen Xu. (2025). Low Selenium Diet Inhibited CaMKII Activation via miR-365-3p/SelT Signaling Axis, Resulting in Myoblast Differentiation Disorders and Skeletal Muscle Damage in Broilers. Biological Trace Element Research. 203(10). 5343–5358. 1 indexed citations

Feng, Dechao, Jie Wang, Dengxiong Li, et al.. (2024). The implications of single-cell RNA-seq analysis in prostate cancer: unraveling tumor heterogeneity, therapeutic implications and pathways towards personalized therapy. Military Medical Research. 11(1). 21–21. 38 indexed citations

Feng, Dechao, Li Li, Xu Shi, et al.. (2023). Identification of senescence-related lncRNA prognostic index correlating with prognosis and radiosensitivity in prostate cancer patients. Aging. 15(18). 9358–9376. 5 indexed citations

Feng, Dechao, Xu Shi, Dengxiong Li, et al.. (2023). M2 macrophage-related molecular subtypes and prognostic index for prostate cancer patients through integrating single-cell and bulk RNA sequencing analysis. Genes & Diseases. 11(4). 101086–101086. 1 indexed citations

Feng, Dechao, et al.. (2023). Membrane tension-mediated stiff and soft tumor subtypes closely associated with prognosis for prostate cancer patients. European journal of medical research. 28(1). 8 indexed citations

Feng, Dechao, Xu Shi, Qiao Xiong, et al.. (2022). A Ferroptosis-Related Gene Prognostic Index Associated With Biochemical Recurrence and Radiation Resistance for Patients With Prostate Cancer Undergoing Radical Radiotherapy. Frontiers in Cell and Developmental Biology. 10. 803766–803766. 23 indexed citations

Feng, Dechao, Xu Shi, Qiao Xiong, et al.. (2022). A Gene Prognostic Index Associated With Epithelial-Mesenchymal Transition Predicting Biochemical Recurrence and Tumor Chemoresistance for Prostate Cancer. Frontiers in Oncology. 11. 805571–805571. 11 indexed citations

Feng, Dechao, Dengxiong Li, Xu Shi, et al.. (2022). A gene prognostic index from cellular senescence predicting metastasis and radioresistance for prostate cancer. Journal of Translational Medicine. 20(1). 252–252. 28 indexed citations

Li, Dengxiong, Xiaoming Wang, Dechao Feng, et al.. (2022). Lymphocyte-to-Monocyte Ratio (LMR) During Induction Is a Better Predictor Than Preoperative LMR in Patients Receiving Intravesical Bacillus Calmette -Guerin for Non-Muscle-Invasive Bladder Cancer. Frontiers in Oncology. 12. 937638–937638. 6 indexed citations

10.

Feng, Dechao, Xu Shi, Wuran Wei, et al.. (2022). Leucine zipper protein 2 serves as a prognostic biomarker for prostate cancer correlating with immune infiltration and epigenetic regulation. Heliyon. 8(10). e10750–e10750. 5 indexed citations

11.

Feng, Dechao, et al.. (2022). The Potential Role of Mitochondrial Acetaldehyde Dehydrogenase 2 in Urological Cancers From the Perspective of Ferroptosis and Cellular Senescence. Frontiers in Cell and Developmental Biology. 10. 850145–850145. 9 indexed citations

12.

Feng, Dechao, Xu Shi, Facai Zhang, et al.. (2022). Energy Metabolism-Related Gene Prognostic Index Predicts Biochemical Recurrence for Patients With Prostate Cancer Undergoing Radical Prostatectomy. Frontiers in Immunology. 13. 839362–839362. 23 indexed citations

13.

Feng, Dechao, Facai Zhang, Dengxiong Li, et al.. (2022). Developing an immune‐related gene prognostic index associated with progression and providing new insights into the tumor immune microenvironment of prostate cancer. Immunology. 166(2). 197–209. 16 indexed citations

14.

Feng, Dechao, Xu Shi, Jia You, et al.. (2022). A cellular senescence-related gene prognostic index for biochemical recurrence and drug resistance in patients with prostate cancer. PubMed Central. 14 indexed citations

15.

Li, Dengxiong, Qingxin Yu, Facai Zhang, et al.. (2022). Systemic Immune-inflammation Index (SII) During Induction has Higher Predictive Value Than Preoperative SII in Non-muscle-invasive Bladder Cancer Patients Receiving Intravesical Bacillus Calmette -Guerin. Clinical Genitourinary Cancer. 21(3). e145–e152. 16 indexed citations

16.

Feng, Dechao, Qiao Xiong, Xu Shi, et al.. (2022). An autophagy-related gene prognostic index predicting biochemical recurrence, metastasis, and drug resistance for prostate cancer. Asian Journal of Andrology. 25(2). 208–216. 3 indexed citations

17.

Feng, Dechao, et al.. (2022). A pan-cancer analysis of the oncogenic role of zinc finger protein 419 in human cancer. Frontiers in Oncology. 12. 1042118–1042118. 15 indexed citations

18.

Feng, Dechao, Xu Shi, Facai Zhang, et al.. (2022). Mitochondria Dysfunction-Mediated Molecular Subtypes and Gene Prognostic Index for Prostate Cancer Patients Undergoing Radical Prostatectomy or Radiotherapy. Frontiers in Oncology. 12. 858479–858479. 17 indexed citations

19.

Shi, Xu, Dechao Feng, & Wuran Wei. (2021). A Systematic Review and Meta-Analysis Protocol of Chemoablation vs. Transurethral Resection of Bladder Tumor in Patients With Non-Muscle-Invasive Bladder Cancer. Frontiers in Surgery. 8. 753547–753547. 4 indexed citations

20.

Shi, Xu, Xiaoming Jiang, Tianming Liu, et al.. (2019). LINC01093 Upregulation Protects against Alcoholic Hepatitis through Inhibition of NF-κB Signaling Pathway. Molecular Therapy — Nucleic Acids. 17. 791–803. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact